Skip to main content
Premium Trial:

Request an Annual Quote

Pronota Raises Additional $1.8M in Financing

a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) —Biomarker developer Pronota has raised an additional €1.5million ($1.8 million) for a total of €7.9 million in its Series B financing round, the company said yesterday.

The Ghent, Belgium-based firm plans to use the funds raised in the round to develop technologies for cardio-renal, pre-eclampsia, sepsis, and ovarian cancer diagnostics.

The latest financing came from MedSciences Capital, the venture arm of the Dutch bank Kempen & Co., and earlier investors in the Series B round included Gimy, Biotech Fund Flanders, LSP, JJDC, KBC Private Equity, VIB, MP Healthcare Venture Management, and Baekeland Fund.

Pronota said that its central platform, which mines for low-abundance protein biomarkers in blood, has been validated by its cardio-renal and other programs, and that it now plans to launch its first diagnostic product in 2012.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.